81675 München, de
+49 (89) 413138-29
New antibody based diagnostic imaging agent demonstrates accuracy in feasibility study
Better treatment planning for kidney cancer thanks to new diagnostic imaging agent / Feasibility study sponsored by the Ludwig Institute for Cancer Research successfully completed.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to firstname.lastname@example.org.